P450 enzymes and Parkinson's disease: the story so far

Movement Disorders : Official Journal of the Movement Disorder Society
A G RiedlC D Marsden

Abstract

Environmental or endogenous toxins may cause nigral cell death in Parkinson's disease (PD) as a result of genetic susceptibility conferred by altered expression of P450 enzymes. Attention over the last 10 years has focused on CYP2D6 polymorphisms and susceptibility to PD. This review summarizes reports arising from both phenotypic and genotypic studies involving CYP2D6 and PD. Phenotypic studies have failed to support a link between CYP2D6 and PD. The more powerful genetic studies initially indicated a link between CYP2D6B mutations and PD, but critical analysis of the literature and recent studies emerging from independent laboratories fail to confirm this. Mutations in CYP2D6B are also not implicated in familial PD. As yet, there is no conclusive evidence to suggest that CYP2D6 polymorphisms confer susceptibility to PD. Whether polymorphisms in other P450s (for example, CYP1A1 and CYP2E1) are implicated in PD remains to be established.

References

Aug 1, 1992·Molecular and Chemical Neuropathology·T Y LiuH C Liu
Aug 1, 1992·Acta Neurologica Scandinavica·M J SteigerP G Jenner
Mar 1, 1991·Acta Neurologica Scandinavica·J KallioE Syvälahti
May 1, 1991·Neurology·W G Johnson
Mar 1, 1990·Annals of Neurology·L I GolbeR C Duvoisin
Aug 1, 1990·Medical Hypotheses·G S ShahiS M Moochhala
Apr 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·J BenitezJ J Muñoz
May 1, 1990·Journal of the Neurological Sciences·M D FerrariO J Buruma
Aug 12, 1989·Lancet·R H WaringA C Williams
Jul 1, 1989·Neurology·G B SteventonA C Williams
Aug 1, 1987·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·C M TannerB S Schoenberg
May 1, 1995·Biochemical Society Transactions·K F Tipton
Mar 1, 1995·Annals of Neurology·S L HoA C Williams
Mar 1, 1995·Clinical Pharmacology and Therapeutics·J A AgúndezF Coria
Jan 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·K Ray-ChaudhuriP N Leigh
Feb 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·K IwahashiT Hayabara
Nov 1, 1994·Clinical Neurology and Neurosurgery·E A PeetersM D Ferrari
Aug 1, 1993·Journal of Biochemistry·Y TsuneokaY Ichikawa
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·I JohanssonM Ingelman-Sundberg
May 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·G S HotamisligilJ Sullivan
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·J P BennettL A Schuh
Nov 1, 1994·Biochemical Pharmacology·J T BorlakK D Haegele
Sep 17, 1994·Lancet·D N Challacombe, E E Wheeler
Jul 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·P MazzettiY Agid
Aug 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·V Planté-BordeneuveA E Harding
Sep 30, 1994·Science·E S Lander, N J Schork
Oct 15, 1993·American Journal of Medical Genetics·M C Kurth, J H Kurth
Jan 1, 1994·Clinical Pharmacology and Therapeutics·J A AgúndezJ Benítez
Apr 1, 1993·Annals of Neurology·J H KurthJ D Schwankhaus
Jul 1, 1996·Neurology·M S SandyJ R Idle

❮ Previous
Next ❯

Citations

Aug 6, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·D M MaraganoreW A Rocca
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·J WangP Chan
Apr 11, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·B S HarhangiM M Breteler
Oct 2, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·A H RajputN Galvez-Jimenez
Apr 22, 2009·Journal of Neural Transmission·H Niazi ShahabiH Nissbrandt
Mar 2, 2011·Journal of Neural Transmission·Chikako KiyoharaUNKNOWN Fukuoka Kinki Parkinson’s Disease Study Group
Mar 1, 2000·Brain Research·P VoirolP Baumann
Feb 15, 2001·European Journal of Pharmacology·D MaimoneL M Grimaldi
Mar 20, 2002·Pharmacology, Biochemistry, and Behavior·Shlomo Yehuda
Jul 11, 2002·Brain Research. Molecular Brain Research·Shankar J ChintaVijayalakshmi Ravindranath
May 18, 2001·Neuroscience Letters·E K TanT Ashizawa
Jun 1, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D G Le CouteurP G Board
Jul 2, 2008·Parkinsonism & Related Disorders·P Jenner
Oct 2, 2002·Journal of Neurochemistry·Sharon MiksysRachel F Tyndale
Oct 8, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Oct 22, 2011·Pharmacogenetics and Genomics·Sohan PuniaRamesh C Juyal
Nov 30, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·M StefanovićM Korsić
Jun 1, 2006·Neuropsychiatric Disease and Treatment·Gin S MalhiPerminder Sachdev
Aug 11, 2004·Clinical Pharmacokinetics·Guillermo GervasiniJulio Benitez
Sep 13, 2012·Pharmacogenomics·Marina KacevskaMagnus Ingelman-Sundberg
Jul 9, 2004·Drug Metabolism Reviews·Sharon Miksys, Rachel F Tyndale
Apr 22, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S L HoD B Ramsden
Jan 3, 2015·Journal of the Neurological Sciences·Ya FengYun-Cheng Wu
Sep 6, 2017·Neurochemical Research·Mohd Sami Ur RasheedMahendra Pratap Singh
Oct 10, 2006·Genetika·M I Shadrina, P A Slominskiĭ
Jan 6, 2004·Nature Biotechnology·Peter H M HoetBenoit Nemery
Oct 31, 2018·The European Journal of Neuroscience·Kurt BraunlichMichael H Thaut
Jun 11, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Katarina StarkF Peter Guengerich
Oct 23, 2002·Molecular Pharmacology·Ralf Peter MeyerUrs A Meyer
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Ai-Ming YuFrank J Gonzalez
Feb 17, 2000·Current Opinion in Neurology·R G Feldman, M H Ratner
Oct 6, 2017·American Journal of Epidemiology·Beate R RitzKimberly McAllister
Oct 20, 2018·International Journal of Molecular Sciences·Oscar Teijido, Ramón Cacabelos
Aug 3, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S MiksysR F Tyndale
Jan 7, 2006·Physiotherapy Theory and Practice·Melinda L Bartscherer, Robin L Dole

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.